H1N1 News and Research

RSS
Novel influenza A (H1N1) is a new flu virus of swine origin that was first detected in Mexico and the United States in March and April, 2009. The first novel H1N1 patient in the United States was confirmed by laboratory testing at CDC on April 15, 2009. The second patient was confirmed on April 17, 2009. It was quickly determined that the virus was spreading from person-to-person. On April 22, CDC activated its Emergency Operations Center to better coordinate the public health response. On April 26, 2009, the United States Government declared a public health emergency.

It’s thought that novel influenza A (H1N1) flu spreads in the same way that regular seasonal influenza viruses spread; mainly through the coughs and sneezes of people who are sick with the virus.
Exploring the interactions between multiple respiratory viruses

Exploring the interactions between multiple respiratory viruses

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

The latest advancements in polymer-based nanotechnology approaches used to fight against SARS-CoV-2

Microbial characteristics of COVID-19

Microbial characteristics of COVID-19

New lab-on-a-chip platform for detecting SARS-CoV-2 in resource-limited settings

New lab-on-a-chip platform for detecting SARS-CoV-2 in resource-limited settings

Transplant recipients benefit from a COVID-19 vaccine booster

Transplant recipients benefit from a COVID-19 vaccine booster

Pre-existing immunity against influenza can lower SARS-CoV-2 infection burden and spread

Pre-existing immunity against influenza can lower SARS-CoV-2 infection burden and spread

rVSV-based bivalent vaccine against SARS-CoV-2 delta variant and influenza

rVSV-based bivalent vaccine against SARS-CoV-2 delta variant and influenza

Risk of Guillain-Barré syndrome decreases after COVID-19 vaccination

Risk of Guillain-Barré syndrome decreases after COVID-19 vaccination

Nanotrap particles can improve current sequencing workflows of SARS-CoV-2

Nanotrap particles can improve current sequencing workflows of SARS-CoV-2

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Researchers discover biomarker that could aid in early detection of high risk COVID-19 patients

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

Natural triterpenoids in licorice found to inhibit SARS-CoV-2

Novel influenza vaccine candidate shows promise

Novel influenza vaccine candidate shows promise

How often does SARS-CoV-2 infect alongside another viruses?

How often does SARS-CoV-2 infect alongside another viruses?

Using metal nanoparticles to fight SARS-CoV-2

Using metal nanoparticles to fight SARS-CoV-2

Discovery of a broad-spectrum antiviral activity in self-assembling immunostimulatory duplex RNAs

Discovery of a broad-spectrum antiviral activity in self-assembling immunostimulatory duplex RNAs

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

Study assesses whether medicinal mushrooms and Chinese herbs can help treat COVID-19

SARS-CoV-2 infection regulates protein arginylation

SARS-CoV-2 infection regulates protein arginylation

SARS-CoV-2 infection in white-tailed deer

SARS-CoV-2 infection in white-tailed deer

Development of SARS-CoV-2 detection platform using surface-enhanced Raman spectroscopy

Development of SARS-CoV-2 detection platform using surface-enhanced Raman spectroscopy

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects

Influenza and COVID vaccines can be co-administered in older adults without causing severe side effects